During the past decade, Indiana CTSI Clinical Research Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 18 clinical trials were completed, i.e. on average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Indiana CTSI Clinical Research Center" #1 sponsor was "Indiana University" with 13 trials, followed by "Gilead Sciences" with 4 trials sponsored, "Sunovion" with 4 trials sponsored, "AstraZeneca" with 3 trials sponsored and "Meda Pharmaceuticals" with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Indiana CTSI Clinical Research Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Purdue University" with 2 trials as a collaborator, "American Heart Association" with 1 trials as a collaborator, "BioAdvantex Pharma" with 1 trials as a collaborator and "Cedars-Sinai Medical Center" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Indiana CTSI Clinical Research Center" are "Cystic Fibrosis" (4 trials), "HIV" (4 trials), "Asthma" (3 trials), "HIV-1 Infection" (3 trials) and "Perennial Allergic Rhinitis" (3 trials). Many other conditions were trialed in "Indiana CTSI Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Indiana CTSI Clinical Research Center" are "Drug" (37 trials), "Biological" (2 trials), "Dietary Supplement" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "IVA" (3 trials), "VX-659/TEZ/IVA" (3 trials), "AC2993" (2 trials) and "B/F/TAF" (2 trials). Other intervention names were less common.

The vast majority of trials in "Indiana CTSI Clinical Research Center" are 38 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Indiana CTSI Clinical Research Center". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Indiana CTSI Clinical Research Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Indiana CTSI Clinical Research Center, 5 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".